Recent developments in less known and multi-resistant fungal opportunists

Area of Science:

• Medical Mycology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Increased incidence of fungal infections linked to host factors like immunosuppression (e.g., AIDS, cancer therapy, transplants).
• Advancements in molecular and proteomic technologies enable identification of previously unrecognized fungal pathogens.
• Emergence of reports on less-common and difficult-to-treat mycoses.

Purpose of the Study:

• To review novel taxonomy of emerging fungal pathogens.
• To discuss clinical presentations, diagnosis, and current treatment of challenging fungal infections.
• To highlight the multi-drug resistance patterns in these fungi.

Main Methods:

• Literature review focusing on recent advancements in mycology.
• Synthesis of information on taxonomy, clinical aspects, and treatment of specific fungal groups.
• Analysis of antifungal resistance trends in emerging fungal species.

Main Results:

• Novel taxonomic classifications for several fungal groups including black fungi, hyaline filamentous fungi, coelomycetes, Mucorales, and non-Candida yeasts.
• These emerging fungal pathogens frequently exhibit multi-drug resistance to antifungals.
• Summary of clinical manifestations, diagnostic approaches, and therapeutic options.

Conclusions:

• Understanding novel taxonomy is crucial for accurate diagnosis and treatment of emerging fungal infections.
• Antifungal resistance is a significant challenge requiring updated treatment guidelines.
• Continued research and surveillance are necessary to combat the rise of recalcitrant mycoses.